Fusion Antibodies: results underwhelm
Fusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m.
Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m.
They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Advanced Medical Solutions
11/01/2023 · Company Insights
Results and updates covered here include news from two small AIM companies in the retail sector,…
14/09/2022 · Company Insights
Two unexpected announcements from online wine retailer Naked Wines suggest that all is not…
More on Argentex Group PLC
26/01/2023 · Company Insights
Results and trading updates from AIM covered in our free update here are generally positive and include plenty…
26/01/2023 · Company Insights
This business had delivered consistent growth over a number of years before the pandemic hit, but…
More on Frasers Group
30/11/2022 · Company Insights
Having experienced a dramatic rise and fall over the past decade, Mulberry faces an uncertain future.…
20/11/2020 · Company Insights
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
More on Fusion Antibodies PLC
20/11/2020 · Company Insights
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
28/04/2020 · Company Insights
Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…
More Company Insights
AIM gains in January, but where are the newcomers?
The rating surely demands a little more excitement!
Another positive update with growth continuing
More on Advanced Medical Solutions
More on Argentex Group PLC
More on Frasers Group
More on Fusion Antibodies PLC
More Company Insights